Modal Container (Shows only in EE)

Modal ID: #cookie-management-modal

Manage My Cookies

Your privacy is important to us. Cookies are very small text files that are stored on your computer when you visit a website. We use cookies and other tracking technologies for a variety of purposes and to enhance your online experience on our website. You can change your preferences and decline certain types of cookies to be stored on your computer while browsing our website. You can also remove any cookies already stored on your computer, but keep in mind that deleting cookies may prevent you from using parts of our website. You can check our privacy policy page for more information.

Always Active
These cookies are essential to provide you with services available through our website and to enable you to use certain features of our website. Without these cookies, we cannot provide you certain services on our website; as a result these cookies do not require your consent.

These cookies are used to show advertising that is likely to be of interest to you based on your browsing habits. These cookies, as served by our content and/or advertising providers, may combine information they collected from our website with other information they have independently collected relating to your web browser's activities across their network of websites.

These cookies are used to provide you with a more personalized experience on our website and to remember choices you make when you use our website. For example, we may use functionality cookies to remember your language preferences or remember your login details.

These cookies are used to collect information to analyze the traffic to our website and how visitors are using our website. For example, these cookies may track things such as how long you spend on the website or the pages you visit which helps us to understand how we can improve our website site for you.
Always Active
These cookies are essential to provide you with services available through our website and to enable you to use certain features of our website. Without these cookies, we cannot provide you certain services on our website; as a result these cookies do not require your consent.

These cookies are used to show advertising that is likely to be of interest to you based on your browsing habits. These cookies, as served by our content and/or advertising providers, may combine information they collected from our website with other information they have independently collected relating to your web browser's activities across their network of websites.

These cookies are used to provide you with a more personalized experience on our website and to remember choices you make when you use our website. For example, we may use functionality cookies to remember your language preferences or remember your login details.

These cookies are used to collect information to analyze the traffic to our website and how visitors are using our website. For example, these cookies may track things such as how long you spend on the website or the pages you visit which helps us to understand how we can improve our website site for you.

Skip to main content

About
Policy Issues
Scientific Innovation
Patient Support

News
Resources
Blog

Sites

MAT.org
PhRMA.org
VotersforCures.org

About
Policy Issues
Scientific Innovation
Patient Support

News
Resources
Blog

Sites

MAT.org
PhRMA.org
VotersforCures.org

Search in PhRMA

All
News
Resources
Blogs

Search

PhRMA Statement on Energy & Commerce Health Subcommittee 340B Hearing

PhRMA CEO John Castellani sent the following letter to the Energy and Commerce Health Subcommittee on the hearing they’re holding on the 340B program

Allyson Funk

Allyson FunkMarch 24, 2015

PhRMA Statement on Energy & Commerce Health Subcommittee 340B Hearing.

Share This

340BSpotlight_Header

Today, PhRMA CEO John J. Castellani sent the following statement for the record to the Energy and Commerce Health Subcommittee on the hearing they’re holding on the 340B program:

Stay Connected

Share

Trending Posts

Ask About Adherence: Improving adherence among osteoporosis patients could save up to $6.52 billion

How the rebate rule would help reduce patients’ out-of-pocket costs

New report finds 15 new oncology therapies launched last year

Members Site
Contact Us
Privacy Policy
Terms of Service
Site Map

Pharmaceutical Research and Manufacturers of America®
670 Maine Avenue, SW, Suite 1000, Washington, DC 20024

Please be advised that this page contains pixel tags. To learn more about what pixel tags are, why and how
we and third parties use pixel tags, and how that use affects you, visit our privacy policy and review
"1. Information Collection."

This website uses cookies and other tracking technologies to optimize performance, preferences, usage, and statistics. By clicking “Accept All”, you consent to store on your device the cookies and other tracking technologies that require consent. You can tailor or change your preferences by clicking “Manage My Cookies”. You can check our privacy policy for more information.